Vaccines, Blood & Biologics

Collection of Blood and Blood Products from Patients with Hemochromatosis

The Center for Biologics Evaluation and Research maintains a list of establishments granted approval for a variance to 21CFR640.3(d) and 21CFR640.3(f) in order to collect blood and blood products from patients with hemochromatosis. 

Key Resources

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 09/17/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English